Stoke Therapeutics, Inc. (STOK)

SEC filing

Stoke Therapeutics, Inc.

STOK · CIK 1623526

4 · Mar 12, 2026 · TZIANABOS ARTHUR sold 4,355 shares at $40.00/share ($174.2K); exercised options for 3,955 shares

TZIANABOS ARTHUR sold 4,355 shares at $40.00/share ($174.2K); exercised options for 3,955 shares

xslF345X05/form4-03122026_080323.xml

xslF345X05/form4-03122026_080323.xmlSEC.gov

Graphics and non-inline formats (not embedded below).